Sestrin 2 inhibits mammalian target of rapamycin (MTORC) and activates the adenosine monophosphate-activated protein kinase (AMPK), the main regulator of energy balance; thus, it has a crucial role in protecting against obesity [35,36]. Here, MTOR is linked to obesity disorder.